Clinical and diagnostic aspects of testosterone deficiency in women of fertile age

Main Article Content

Z.Yu. Khalimova
A.A. Almakhmatova

Abstract

Background. The role of androgens in a woman has not been fully appreciated. Currently, there is no clear and gene­rally accepted definition of the concept of androgen deficiency in women by analogy with that in men. The purpose of the study was to investigate the clinical and diagnostic aspects of testoste­rone deficiency in women of fertile age. Materials and methods. The study included 60 women with testosterone deficiency without other concomitant pathology. The average age of the patients was 28.3 years. The control group consisted of 20 healthy women. The patients were divided into three groups based on their body mass index (BMI). The first group consisted of 20 overweight women (BMI 25–29.9 kg/m2), the second group — 20 women with first-degree obesity, and the third group — 20 women with second-degree obesity. Results. On the 14th day of the ovarian-menstrual cycle, the patients from the first group showed a tendency towards a decrease in the basal levels of luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, and progesterone against the background of significant hypoandrogenaemia. Patients with obesity (II degree) showed a significant decrease in basal levels of LH, FSH, estradiol, progesterone against the background of significant hypoandrogenaemia. The correlation analysis revealed a direct relationship between testosterone deficiency and obesity. Thus, the lowest testosterone values were found in patients of the third group (< 0.05 nmol/l). At the same time, the testosterone level in the patients of the first and second groups was also significantly reduced — from 0.02 to 0.05 nmol/l, respectively. The levels of dehydroepiandrosterone and 17-hydroxycorticosteroids were significantly reduced, especially in the third group — 0.3 μg/ml and 0.1 nmol/l, respectively. Conclusions. Most women of reproductive age with testosterone deficiency have hypomenorrhea with low free testosterone. A direct correlation was established between testosterone deficiency and the degree of obesity in women with androgen deficiency.

Article Details

How to Cite
Khalimova, Z., and A. Almakhmatova. “Clinical and Diagnostic Aspects of Testosterone Deficiency in Women of Fertile Age”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 17, no. 1, Apr. 2021, pp. 81-85, doi:10.22141/2224-0721.17.1.2021.226436.
Section
Original Researches

References

Bienenfeld A, Azarchi S, Lo Sicco K, Marchbein S, Shapiro J, Nagler AR. Androgens in women: Androgen-mediated skin disease and patient evaluation. J Am Acad Dermatol. 2019 Jun;80(6):1497-1506. doi:10.1016/j.jaad.2018.08.062.

Azarchi S, Bienenfeld A, Lo Sicco K, Marchbein S, Shapiro J, Nagler AR. Androgens in women: Hormone-modulating therapies for skin disease. J Am Acad Dermatol. 2019 Jun;80(6):1509-1521. doi:10.1016/j.jaad.2018.08.061.

Carbajal-García A, Reyes-García J, Montaño LM. Androgen Effects on the Adrenergic System of the Vascular, Airway, and Cardiac Myocytes and Their Relevance in Pathological Processes. Int J Endocrinol. 2020 Nov 12;2020:8849641. doi:10.1155/2020/8849641.

Burger HG, Papalia MA. A clinical update on female androgen insufficiency--testosterone testing and treatment in women presenting with low sexual desire. Sex Health. 2006 May;3(2):73-8. doi:10.1071/sh05055.

Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005 Jul;90(7):3847-53. doi:10.1210/jc.2005-0212.

Sturdee DW, Pines A; International Menopause Society Writing Group. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric. 2011 Jun;14(3):302-20. doi:10.3109/13697137.2011.570590.

Wierman ME, Basson R, Davis SR, et al. Androgen therapy in women: an Endocrine Society Clinical Practice guideline. J Clin Endocrinol Metab. 2006 Oct;91(10):3697-710. doi:10.1210/jc.2006-1121.

Vegunta S, Kling JM, Kapoor E. Androgen Therapy in Women. J Womens Health (Larchmt). 2020 Jan;29(1):57-64. doi:10.1089/jwh.2018.7494.

Arlt W. Androgen therapy in women. Eur J Endocrinol. 2006 Jan;154(1):1-11. doi:10.1530/eje.1.02062.

Braunstein GD. Androgen insufficiency in women: summary of critical issues. Fertil Steril. 2002 Apr;77 Suppl 4:S94-9. doi:10.1016/s0015-0282(02)02962-x.

Mathur R, Braunstein GD. Androgen deficiency and therapy in women. Curr Opin Endocrinol Diabetes Obes. 2010 Aug;17(4):342-9. doi:10.1097/MED.0b013e32833ab083.

Mohamed O, Freundlich RE, Dakik HK, et al. The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism. Int J Impot Res. 2010 Jan-Feb;22(1):20-4. doi:10.1038/ijir.2009.35.

Chueh KS, Huang SP, Lee YC, et al. The comparison of the aging male symptoms (AMS) scale and androgen deficiency in the aging male (ADAM) questionnaire to detect androgen deficiency in middle-aged men. J Androl. 2012 Sep-Oct;33(5):817-23. doi:10.2164/jandrol.111.015628.

Glaser R, Dimitrakakis C. Testosterone therapy in women: myths and misconceptions. Maturitas. 2013 Mar;74(3):230-4. doi:10.1016/j.maturitas.2013.01.003.

Rivera-Woll LM, Papalia M, Davis SR, Burger HG. Androgen insufficiency in women: diagnostic and therapeutic implications. Hum Reprod Update. 2004 Sep-Oct;10(5):421-32. doi:10.1093/humupd/dmh037.

Tyagi V, Scordo M, Yoon RS, Liporace FA, Greene LW. Revisiting the role of testosterone: Are we missing something? Rev Urol. 2017;19(1):16-24. doi:10.3909/riu0716.

Pavičić Baldani D, Škrgatić L, Bukvić Mokos Z, Trgovčić I. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome. Acta Dermatovenerol Croat. 2013;21(2):105-12.

Morales A, Collier CP, Clark AF. A critical appraisal of accuracy and cost of laboratory methodologies for the diagnosis of hypogonadism: the role of free testosterone assays. Can J Urol. 2012 Jun;19(3):6314-8.

Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2006 Jun;91(6):1995-2010. doi:10.1210/jc.2005-2847.

Bassil N, Alkaade S, Morley JE. The benefits and risks of testosterone replacement therapy: a review. Ther Clin Risk Manag. 2009 Jun;5(3):427-48. doi:10.2147/tcrm.s3025.

Most read articles by the same author(s)

1 2 > >>